SLC7A11 inhibitors could remove skin cancer’s protective armour
Scientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from hostile environments and allowing one of the deadliest forms of skin cancer to spread through the body.
A team of researchers from The Institute of Cancer Research, London, has identified that a protein called SLC7A11 protects melanoma cells from damage as they pass through stressful environments in the body – allowing them to grow and spread unchecked.
The findings could open new avenues of research to disable the disease’s defences, offering fresh hope for thousands of patients.
Normally, cells are vulnerable to a process called oxidative stress – a kind of internal ‘rusting’ that damages and destroys them.
In research funded by Cancer Research UK, UK Research and Innovation (UKRI), Worldwide Cancer Research, Breast Cancer Now and Barts Charity, the team grew melanoma tumours in the lab.
They saw that the more aggressive cells in the tumour – those around the border, with a rounder shape which enables them to invade other tissues – produced high amounts of the protein SLC7A11, which protects against oxidative stress.
They found that SLC7A11 acts not only as a protective shield against oxidative stress, but also as a suit of armour, controlling the cytoskeleton of the cancer cells – a structure that helps them become mobile and aggressive.
When they knocked out the protein and stopped it from working, the cells were less round, and less able to grow and invade; after 72 hours, almost 75% of the cells had died.
Leaving cancer cells exposed
The ICR researchers hope that targeted SLC7A11 inhibitors can be developed in the future and trialled for the treatment of melanoma.
Professor Victoria Sanz-Moreno, Professor of Cancer Cell and Metastasis Biology at The Institute of Cancer Research, London, who led the study said: “Our study has helped us to better understand how some cancer cells protect themselves from the stresses they encounter as they attempt to spread around the body. This could lead to new ways to identify and treat aggressive melanoma.
“High levels of the SLC7A11 protein seems to be a warning sign that a tumour is likely to spread. We have shown in the lab that targeting this protein leaves the cancer cells exposed and vulnerable to oxidative stress, blocking their ability to invade other tissues. If we take away the melanoma cells’ shield and armour, we could stop cancer in its tracks.”
Diana Turner, Senior Digital Content Editor, DDW
